Elevance Health names Mark Kaye new CFO to succeed retiring John Gallina; reaffirms 2023 guidance

Elevance Health, Inc.

Mark Kaye appointed EVP and CFO effective Nov 1, 2023; will serve as CFO Designate starting Sep 6.
John Gallina retiring after ~30 years at company; will remain as Special Advisor to CEO post-transition.
Kaye's compensation: base salary $900k, target bonus 120% of base, LTI target $5.5M; one-time awards: $8M RSUs, $3.7M equity mix, and $2.5M cash.
Kaye previously CFO at Moody's (2018-2023), held senior finance roles at MassMutual and Voya.
Company reaffirms FY 2023 adjusted net income guidance > $32.85 per share; net income > $29.09 per share.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Mark Kaye

Executive Vice President and Chief Financial Officer

ELV · Elevance Health, Inc.

Effective: 2023-11-01
Filed: August 8, 2023, 7:59 PM ET

On August 8, 2023, Elevance Health, Inc. (the “Company”) announced that Mark Kaye has been named Executive Vice President and Chief Financial Officer (“CFO”) of the Company, effective November 1, 2023 (the “Transition Date”).

Departed

John Gallina

Chief Financial Officer

ELV · Elevance Health, Inc.

Effective: 2023-11-01
Successor: Mark Kaye
Filed: August 8, 2023, 7:59 PM ET

Mr. Kaye succeeds John Gallina, who, after nearly thirty years of dedicated services to the Company, has decided to retire as CFO.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Kaye was appointed as Executive Vice President and Chief Financial Officer at Elevance Health, Inc..

Action: appointed
Role: Executive Vice President and Chief Financial Officer

Exact text from the filing

On August 8, 2023, Elevance Health, Inc. (the “Company”) announced that Mark Kaye has been named Executive Vice President and Chief Financial Officer (“CFO”) of the Company, effective November 1, 2023 (the “Transition Date”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

John Gallina retired as Chief Financial Officer at Elevance Health, Inc..

Action: retired
Role: Chief Financial Officer

Exact text from the filing

Mr. Kaye succeeds John Gallina, who, after nearly thirty years of dedicated services to the Company, has decided to retire as CFO.

View on SEC.gov

Elevance Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-205527

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.